Public Health England Knowledge and Intelligence Team (South West), Bristol, UK.
Public Health England Knowledge and Intelligence Team (South West), Bristol, UK.
Eur Urol. 2015 Jun;67(6):1056-1062. doi: 10.1016/j.eururo.2014.12.002. Epub 2014 Dec 17.
The Improving Outcomes in Urological Cancers guidelines recommended centralisation of cystectomy services to improve outcomes for bladder cancer (BCa) patients.
To investigate trends in all-cause and cause-specific survival to see if there was an improvement in survival after centralisation was implemented. To analyse trends in the number of acute hospital trusts undertaking cystectomy.
DESIGN, SETTING, AND PARTICIPANTS: We used routine data to capture information on radical cystectomy (RC) in BCa patients aged 20 yr and older between 1998 and 2010 (n=16,033).
We calculated 30-d and 90-d mortality, and 30-d, 90-d, 1-yr, and 5-yr survival. The average number of RCs per trust was derived. Trends were identified using regression analysis.
The 30-d crude mortality decreased from 5.2% to 2.1% (p<0.001) and 90-d crude mortality decreased from 10.3% to 5.1% (p<0.001). There was an increase in 30-d relative survival from 96% to 98% (p<0.001), in 90-d relative survival from 91% to 96% (p<0.001), in 1-yr relative survival from 71% to 80% (p<0.001), and in 5-yr relative survival from 49% to 56% (2004-2006 data; p<0.001). The mean number of RCs performed by trusts in England increased from six to 24 (p<0.001). Smoking status and stage at diagnosis were not available.
Survival after RC has increased alongside decreases in short-term mortality. There is little evidence of a cohort effect. The trends in survival are linear and we conclude that the continued survival improvements are a result of a combination of service improvements that include service reconfiguration, improved surgical training, neoadjuvant chemotherapy, enhanced recovery principles, and continued improvements in perioperative care.
We analysed routinely collected hospital data. Outcomes for patients who undergo cystectomy have improved for all age groups. This is likely to be due to a combination of changes in practice.
改善泌尿系统癌症治疗效果指南建议对膀胱切除术服务进行集中管理,以改善膀胱癌 (BCa) 患者的治疗效果。
调查全因和特定原因生存率的趋势,以确定集中治疗后是否改善了生存率。分析开展根治性膀胱切除术的急性医院信托数量的趋势。
设计、设置和参与者:我们使用常规数据来获取 1998 年至 2010 年间年龄在 20 岁及以上的膀胱癌患者根治性膀胱切除术 (RC) 的信息(n=16033)。
我们计算了 30 天和 90 天死亡率,以及 30 天、90 天、1 年和 5 年生存率。计算每个信托机构的 RC 平均数量。使用回归分析确定趋势。
30 天的粗死亡率从 5.2%降至 2.1%(p<0.001),90 天的粗死亡率从 10.3%降至 5.1%(p<0.001)。30 天相对生存率从 96%升至 98%(p<0.001),90 天相对生存率从 91%升至 96%(p<0.001),1 年相对生存率从 71%升至 80%(p<0.001),5 年相对生存率从 49%升至 56%(2004-2006 年数据;p<0.001)。英格兰信托机构实施 RC 的平均数量从 6 例增加到 24 例(p<0.001)。吸烟状况和诊断时的分期不可用。
RC 后生存率的提高伴随着短期死亡率的降低。几乎没有证据表明存在队列效应。生存率的趋势是线性的,我们得出结论,持续的生存改善是服务改进的综合结果,包括服务重组、提高手术培训、新辅助化疗、强化恢复原则以及持续改进围手术期护理。
我们分析了常规收集的医院数据。所有年龄段患者的膀胱切除术治疗效果都有所改善。这可能是由于实践的变化。